Altamira Therapeutics LTD. (CYTOF) — 20-F Filings
All 20-F filings from Altamira Therapeutics LTD.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
Altamira Therapeutics Files 2024 Annual Report
— Apr 30, 2025 Risk: medium
Altamira Therapeutics Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, formerly known as Auris Medical Holdin -
Altamira Therapeutics Ltd. Files Annual Report on Form 20-F
— Apr 10, 2024 Risk: low
Altamira Therapeutics Ltd. (CYTOF) filed a Foreign Annual Report (20-F) with the SEC on April 10, 2024. Altamira Therapeutics Ltd. filed its annual report on Fo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX